ALLMedicine™ Trigeminal Neuralgia Center

May 18th, 2022 - Ambroxol is a multifaceted drug with primarily mucoactive and secretolytic actions, along with anti-inflammatory, antioxidant, and local anaesthetic properties. It has a long history of use in the treatment of respiratory tract diseases and has sh...

May 15th, 2022 - Surgical resolution of trigeminal neuralgia complicating vestibular schwannoma removal.|2022|Bonaudo C,Esposito A,Spalletti M,Pecchioli G,Trabalzini F,|

May 8th, 2022 - Novel ways of approaching the pharmacologic treatment of trigeminal neuralgia.|2022|Dominguez M,Di Stefano G,|

May 8th, 2022 - Despite some advances, treatment of trigeminal neuralgia remains a significant challenge. This study determines the efficacy and safety of autologous conditioned serum (Orthokine) injection into the foramen oval to treat refractory trigeminal neur...

May 7th, 2022 - Trigeminal neuralgia (TN) is a type of transient and paroxysmal recurrent severe pain confined to the trigeminal nerve region. This study systematically evaluated the efficacy and safety of microvascular decompression (MVD) and percutaneous balloo...

Jan 9th, 2018 - What surgical approaches for vestibular schwannomas (VS) are best for complete resection and facial nerve (FN) preservation when serviceable hearing is present? There is insufficient evidence to support the superiority of either the middle fossa (...

Jul 22nd, 2009 - Trigeminal neuralgia is a common cause of facial pain. It has a significant impact on the quality of life and the socioeconomic functioning of the patient. The aim of this review is to provide recommendations for medical management of trigeminal n...

Mar 21st, 2022 - The purpose of this study is to assess the safety and effectiveness of MRI-guided focused ultrasound (MRgFUS) for treating Trigeminal Neuralgia. Trigeminal Neuralgia (pain) is a type of pain involving the face that can be disabling to those it aff...

Mar 16th, 2022 - Trigeminal neuralgia (TN) was defined by The International Association for the Study of Pain (IASP) as severe, sudden, usually unilateral, stabbing, brief, recurrent attacks of pain in one or more distributional branches of the trigeminal nerve. T...

Mar 10th, 2022 - A total of 120 subjects with CTN who met the inclusion criteria will be included in the study. The subjects will be randomly divided into EA+ Carbamazepine group, EA+placebo group, sham EA+Carbamazepine group and sham EA+placebo group. The indexes...

Feb 28th, 2022 - A phenome-wide association study (PheWAS) identified an association between a loss of function variant in the human alpha 2B adrenergic receptor gene and trigeminal nerve disorders. Guanfacine is the oldest alpha-2 adrenergic agonist in clinical u...

Dec 23rd, 2021 - Chemotherapy Induced Peripheral Neuropathy Chemotherapy induced peripheral neuropathy (CIPN) is a common adverse effect of cancer therapy, effecting over half of all patients who receive chemotherapy. CIPN typically manifests as a symmetrical, pre...

Jan 19th, 2022 - Key clinical point: Women presenting with multiple sclerosis (MS) are more likely to develop trigeminal neuralgia (TN) relative to men with MS. Major finding: The estimated pooled TN prevalence in the overall population was 3.

Nov 12th, 2021 - NEW ORLEANS — Intraorbital frontal nerve resection appears effective for some patients with idiopathic trigeminal neuralgia where the ophthalmic division (V1) is involved, researchers say. The procedure offers long-term relief in a condition where...

Oct 1st, 2020 - The National Institute for Health and Care Excellence (NICE) has published updated recommendations on the management of neuropathic pain. Key recommendations are summarised below: Principles of care When agreeing a treatment plan with the person d...

Apr 5th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. Since the Centers for Disease Control and Prevention (CDC) confirmed the first US case of novel coronavirus infection on January 20, much of the ...

Apr 2nd, 2020 - Key clinical point : The incidence of trigeminal neuralgia (TN) is 15-fold higher in patients with multiple sclerosis (MS) compared with the general neurological outpatient population. Major finding : Concomitant diagnoses of MS and TN were verifi.